|
|
| (11) | Number of the document | C 1524993 |
| (68) | Number of the document | 1524993 |
| (21) | Application number for Supplementary Protection Certificate | PA 2013 021 |
| (22) | Date of filing the application | 2013-09-04 |
| (41) | Date of publication of the application | 2013-10-25 |
| Date of publication of SPC | 2014-06-25 | |
| (24) | Date of coming into effect of SPC | 2023-08-01 |
| (71) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart Brussels,
BE
|
| (73) |
GlaxoSmithKline Biologicals s.a.,
rue de l`Institut 89, 1330 Rixensart Brussels,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/12/812/001, 2013 01 14 EU/1/12/812/002, 2013 01 14 EU/1/12/812/003, 2013 01 14 EU/1/12/812/004, 2013-01-14 |
| (94) | 2028-01-14 |
| (95) | Neisseria meningitidis NHBA baltymas + Neisseria meningitidis NadA baltymas + išorinės membranos vezikulės iš Neisseria meningitidis |
| SPC lapsed (non-payment of fees for the main patent) |